MY138934A - Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride - Google Patents

Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Info

Publication number
MY138934A
MY138934A MYPI20032577A MY138934A MY 138934 A MY138934 A MY 138934A MY PI20032577 A MYPI20032577 A MY PI20032577A MY 138934 A MY138934 A MY 138934A
Authority
MY
Malaysia
Prior art keywords
indol
piperidin
ylmethyl
dione
pyridin
Prior art date
Application number
Inventor
Julie Kay Bush
Margaret Mary Faul
Susan Marie Reutzel-Edens
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to MYPI20032577 priority Critical patent/MY138934A/en
Publication of MY138934A publication Critical patent/MY138934A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[ 1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE SALT, A PHARMACEUTICAL FORMULATION CONTAINING SAID SALT AND TO METHODS FOR TREATING CANCER AND FOR INHIBITING TUMOR GROWTH USING SAID SALT.
MYPI20032577 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride MY138934A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20032577 MY138934A (en) 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20022777 MY139957A (en) 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride
MYPI20032577 MY138934A (en) 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Publications (1)

Publication Number Publication Date
MY138934A true MY138934A (en) 2009-08-28

Family

ID=45699544

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI20022777 MY139957A (en) 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride
MYPI20032577 MY138934A (en) 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MYPI20022777 MY139957A (en) 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride

Country Status (1)

Country Link
MY (2) MY139957A (en)

Also Published As

Publication number Publication date
MY139957A (en) 2009-11-30

Similar Documents

Publication Publication Date Title
HRP20050035B1 (en) Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
IL171976A0 (en) Indazole, benzisoxazole, and banzisothiazole kinase inhibitors
AP9901478A0 (en) Compounds for the treatment of ischemia.
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
YU61402A (en) Pyrrole substituted 2-indolinone protein kinase inhibitors
PL406680A1 (en) Tyrosine kinase inhibitors
WO2003051366A3 (en) 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
TW200621715A (en) Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
TR200200205T2 (en) Treating chronic pain using MEK inhibitors
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
ATE381557T1 (en) RHO KINASE INHIBITORS
MY143599A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
EP1617840A4 (en) Pyrazole-amide compounds useful as kinase inhibitors
RS20050116A (en) Novel phenanthridines
RS60404A (en) Controlled synthesis of ziprasidone and compositions thereof
IL162203A0 (en) Indolinone derivatives useful as protein inase inhibitors
HK1085675A1 (en) Anticancer compounds
MXPA05009611A (en) SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS.
WO1992020336A3 (en) Novel cholesterol lowering compounds
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
MXPA02000330A (en) Neurotrophic pyrrolidines and piperidines, and related compositions and methods.
WO2004058705A3 (en) Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
MXPA03004879A (en) Farnesyltransferase inhibitors.
MY138934A (en) Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
TW200503722A (en) Substituted 7-aza-quinazoline compounds